1. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients. (4th March 2021) Authors: Bhattacharjee, Sourav; Brayden, David J. Journal: Expert opinion on drug discovery Issue: Volume 16:Number 3(2021) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. (February 2015) Authors: Kelly, Julie A.; Boyle, Noreen T.; Cole, Natalie; Slator, Gillian R.; Colivicchi, M. Alessandra; Stefanini, Chiara; Gobbo, Oliviero L.; Scalabrino, Gaia A.; Ryan, Sinead M.; Elamin, Marwa; Walsh, Cathal; Vajda, Alice; Goggin, Margaret M.; Campbell, Matthew; Mash, Deborah C.; O'Mara, Shane M.; Bra... Journal: Neuropharmacology Issue: Volume 89(2015) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatic gateways. (3rd May 2016) Authors: Udupa, K. Venkatesha; Brayden, David J.; Winter, Desmond C.; Baird, Alan W. Journal: Expert review of gastroenterology & hepatology Issue: Volume 10:Number 5(2016) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High-content analysis for drug delivery and nanoparticle applications. Issue 8 (August 2015) Authors: Brayden, David J.; Cryan, Sally-Ann; Dawson, Kenneth A.; O'Brien, Peter J.; Simpson, Jeremy C. Journal: Drug discovery today Issue: Volume 20:Issue 8(2015) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans. (1st February 2021) Authors: Maher, Sam; Geoghegan, Caroline; Brayden, David J. Journal: Expert opinion on drug delivery Issue: Volume 18:Number 2(2021) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Introduction for the special issue on recent advances in drug delivery across tissue barriers. Issue 2 (2nd April 2016) Authors: Mrsny, Randall J.; Brayden, David J. Journal: Tissue barriers Issue: Volume 4:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oral delivery strategies for nutraceuticals: Delivery vehicles and absorption enhancers. (July 2016) Authors: Gleeson, John P.; Ryan, Sinéad M.; Brayden, David J. Journal: Trends in food science & technology Issue: Volume 53(2016) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety concerns over the use of intestinal permeation enhancers: A mini-review. Issue 2 (2nd April 2016) Authors: McCartney, Fiona; Gleeson, John P.; Brayden, David J. Journal: Tissue barriers Issue: Volume 4:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TNFα-dependent anhedonia and upregulation of hippocampal serotonin transporter activity in a mouse model of collagen-induced arthritis. (15th July 2018) Authors: Brown, Eric; Mc Veigh, Conor J.; Santos, Leilani; Gogarty, Martina; Müller, Heidi Kaastrup; Elfving, Betina; Brayden, David J.; Haase, Jana Journal: Neuropharmacology Issue: Volume 137(2018) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation. (3rd October 2021) Authors: Brayden, David J.; Maher, Sam Journal: Expert opinion on drug delivery Issue: Volume 18:Number 10(2021) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗